| Supratentorial Glioblastoma studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177964Phase 2 · recruiting Lerapolturev (PVSRIPO) in GBM · condition mapped CURATED_BROADER · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04105374Phase 2/Phase 3 · withdrawn Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04479241Phase 2 · completed LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01430351Phase 1 · terminated Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732352Phase 2 · completed 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311920Phase 1 · completed Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04854044Phase 1 · withdrawn ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04674579unknown Automatic Segmentation MRI Cerebral Glioma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Cerebral Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03997136unknown Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00884741Phase 3 · completed Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active) | — | — | Supratentorial Glioblastoma | 1 | Observed | clinicaltrials | graph → |